Literature DB >> 13609591

Novobioci as uncoupling agent.

J FREI, N CANAL, E GORI.   

Abstract

Keywords:  ANTIBIOTICS/effects; METABOLISM, TISSUE/effect of drugs on

Mesh:

Substances:

Year:  1958        PMID: 13609591     DOI: 10.1007/bf02159165

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  12 in total

1.  Some liver enzymes during dicumarol treatment and vitamin K-deficiency.

Authors:  J P GREEN; E SONDERGAARD; H DAM
Journal:  J Pharmacol Exp Ther       Date:  1957-01       Impact factor: 4.030

2.  Phosphorylation coupled to oxidation in bacterial extracts.

Authors:  A F BRODIE; C T GRAY
Journal:  J Biol Chem       Date:  1956-04       Impact factor: 5.157

3.  Studies on the mode of action of novobiocin.

Authors:  T D BROCK
Journal:  J Bacteriol       Date:  1956-09       Impact factor: 3.490

4.  Phosphorylation coupled to electron transport in cell-free extracts of Alcaligenes faecalis.

Authors:  G B PINCHOT
Journal:  J Biol Chem       Date:  1953-11       Impact factor: 5.157

5.  [The mechanism of action of dicumarol and related compounds].

Authors:  C MARTIUS; D NITZ-LITZOW
Journal:  Biochim Biophys Acta       Date:  1953 Sep-Oct

6.  Oxidative phosphorylation.

Authors:  H A KREBS; A RUFFO; M JOHNSON; L V EGGLESTON; R HEMS
Journal:  Biochem J       Date:  1953-04       Impact factor: 3.857

7.  Inhibition of cleavage and P32 uptake in Arbacia by d-usnic acid.

Authors:  A MARSHAK; J HARTING
Journal:  J Cell Comp Physiol       Date:  1948-06

8.  Reversible inhibition of the coupling between phosphorylation and oxidation.

Authors:  W F LOOMIS; F LIPMANN
Journal:  J Biol Chem       Date:  1948-04       Impact factor: 5.157

9.  The mode of action of the antibiotic, usnic acid.

Authors:  R B JOHNSON; G FELDOTT; H A LARDY
Journal:  Arch Biochem       Date:  1950-10

10.  Phosphorylation due to the oxidation of succinic acid by cell-free extracts of Escherichia coli.

Authors:  D F HERSEY; S J AJL
Journal:  J Gen Physiol       Date:  1951-01       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.